In this work, we hypothesized that p53 reactivationusing ATSP-7041would prime DLBCL for apoptosis via the BCL-2 family of proteins andsensitize it to therapeutic cell death by ABT-263. This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.